Tales From The Road
This panel brings together biotech and medtech entrepreneurs to tell their stories of raising capital. You’ll hear their firsthand accounts of navigating the fundraising process and raising capital. Topics may include:
• What stumbling blocks had they hit?
• How had they solved the issues, and what had they learned about raising capital?
• How did they go about finding potential investors, and how did they determine which investors they should pursue?
The panel discusses what the early stage fundraising process was like for them and how others can build an outbound marketing campaign to raise money.
Kathie Callahan Brady, CEO, Frederick Innovation Technology Center (FITCI)
Kathie Callahan Brady masterfully leads entrepreneurs and corporations in strategies to achieve high-level success. Her proven track record has allowed her to found four successful companies in various industries and generate millions of dollars in revenue. Kathie is a distinguished entrepreneur, highly sought-after speaker, lauded author, and educator. She was a partner in Quantum Realty Capital specializing in commercial real estate & financing. She founded Future CEO to empower entrepreneurs to start and operate their own businesses. Kathie has helped hundreds of Companies raise funding & grow significantly. She feels privileged to work with the top 5% who step up, assumes leadership, & make a tangible difference. Today, she works with some of the most gifted Biotech and Technology companies as CEO of Frederick Innovative Technology Center. Her passion is to help owners turned around, increase profits and achieve a better- quality life.
Ajay Rai, VP, Business Development, Frequency Therapeutics
Ajay is the Vice President, Business Development of Frequency Therapeutics. He has over 20 years in finance, strategy and business development/M&A experience in the Life Sciences arena. Prior to joining Frequency, Ajay was the Senior Director of Corporate Development for Takeda. In this role, Ajay was responsible for evaluating and leading M&A, divestments, joint ventures and new company formation for all of Takeda’s business. Prior to Takeda, Ajay spent over 10 years at Biogen in a variety of roles, including Business Planning, Investor Relations, Corporate Strategy, Venture Investment and Business Development/M&A. Ajay was responsible for leading BD activities for immunology, pain and tissue injury and fibrosis therapeutic areas. Ajay has also had investment banking and M&A advisory roles for various financial institutions earlier in his career.
Rick Berenson, Angel Investor, Mass Medical Angels
Rick is a serial entrepreneur who has successfully launched and financed multiple life science and other organizations around important new technologies in complex markets. He has been CEO or COO of eleven companies; most recently Thermalin Diabetes, LLC (CEO, biotech) and HeartLander Surgical, Inc. (CEO, medical device). Rick has led companies in consumer products manufacturing, knowledge management, new media, entertainment industry technology, manufacturing software, healthcare information and services, healthcare market research, diagnostic reference laboratory services, and cancer immunotherapeutics. He has raised or helped raise more than $50M in private and non-dilutive capital. A former McKinsey & Company consultant, Rick received a JD-MBA from Harvard Business and Law Schools in 1984 and is a graduate of Harvard College.
Jon Rowley, Founder, RoosterBio
Jon A. Rowley, PhD, is the Founder and Chief Product Officer of RoosterBio Inc and has a personal goal of making significant contributions to the commercial translation of living cellular technologies. Jon holds a PhD from the University of Michigan in Biomedical Engineering and has authored over 35 peer reviewed manuscripts and 20 issued or pending patents related to biomaterials development, tissue engineering, and cellular therapy. He most recently spent 5 years as Director of Innovation and Process Development in Lonza’s Cell Therapy CMO business, and currently resides in Walkersville, MD with his wonderful wife and their 3 young children.
David Narrow, CEO, Sonavex
David Narrow is co-founder and CEO of Sonavex Inc., a venture-backed commercial stage medical device company spun-out of Johns Hopkins University. The company develops and commercializes ultrasound products for surgeons, including a technology for detecting post-operative blood clots. His first venture, MonoMano Inc., provides rehabilitative, general health, and social benefits to stroke survivors by making cycling accessible for those with functional use of a single arm and leg. David previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy as a healthcare consultant at Health Advances LLC. Narrow was named 30 Under 30 in Healthcare by Forbes in 2016 and 40 Under 40 in the Baltimore Business Journal in 2017.